Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Translational Oncology|September 1, 2012
Angiogenic alterations associated with circulating neoplastic DNA in ovarian carcinomaTilley Jenkins Vogel, Christiana Dellorusso, Piri Welcsh, et al.
Journal of Gynecologic Oncology|November 8, 2014
An analysis of current treatment practice in uterine papillary serous and clear cell carcinoma at two high volume cancer centersTilley Jenkins Vogel, Abhay Knickerbocker, Chirag A Shah, et al.
American Journal of Obstetrics and Gynecology|March 18, 2011
Surgical outcomes in gynecologic oncology in the era of robotics: analysis of first 1000 casesPamela J Paley, Dan S Veljovich, Chirag A Shah, et al.
Gynecologic Oncology|January 25, 2011
Pelvic exenteration in the age of modern chemoradiationKate A McLean, Weiya Zhang, Rebecca F Dunsmoor-Su, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|February 19, 2024
Same day discharge colon surgery: is it financially worth it?Karleigh R Curfman, Gabrielle E Blair, Callan L Kosnik, et al.
Gynecologic Oncology|February 8, 2008
An evaluation of cervical cancer in women age sixty and overKatrina V Fox, Chirag A Shah, Elizabeth M Swisher, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 9, 2009
Influence of ovarian cancer risk status on the diagnostic performance of the serum biomarkers mesothelin, HE4, and CA125Chirag A Shah, Kimberly A Lowe, Pamela Paley, et al.
European Journal of Gynaecological Oncology|March 6, 2023
Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution studyTalayeh S Ghezelayagh, Emily S Wu, Emma L Barber, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|February 1, 2019
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patientsSaul Eugene Rivkin, James Moon, Desiree S Iriarte, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 7, 2025
Comparing Durvalumab, Olaparib, and Cediranib Monotherapy, Combination Therapy, or Chemotherapy in Patients with Platinum-Resistant Ovarian Cancer with Prior Bevacizumab: The Phase II NRG-GY023 TrialJung-Min Lee, Austin Miller, Peter G Rose, et al.
Pageof 3